As Health Canada is set to approve the COVID-19 vaccine for use in Canada any day now, here is a list of companies Canada has signed an agreement with to secure access to their COVID-19 vaccine candidates:
- Pfizer, which will supply a minimum of 20 million doses and up to 76 million doses of its messenger RNA (mRNA) vaccine candidate developed with BioNTech, BNT162b2.
- Medicago, which will supply up to 76 million doses of its virus-like particle vaccine candidate.
- AstraZeneca, which will supply up to 20 million doses of its viral vector vaccine candidate AZD1222.
- Sanofi and GlaxoSmithKline, which will supply up to 72 million doses of their protein subunit vaccine candidate.
- Johnson & Johnson, which will supply up to 38 million doses of its viral vector vaccine candidate Ad26.COV2.S.
- Novavax, which will supply up to 76 million doses of its protein subunit vaccine candidate NVX-CoV2373.
- Moderna, which will supply up to 56 million doses of its mRNA vaccine candidate mRNA-1273.
All vaccine candidates must go through pre-clinical and clinical trials.
The Government of Canada has also purchased 126 freezers to store COVID-19 vaccines, including 26 freezers to store ultra-low temperature vaccines such as the Pfizer vaccine. To date, 9 ultra-low temperature freezers have been delivered.
Canada will receive up to 249,000 doses of the Pfizer-BioNTech COVID-19 vaccine in December 2020.